Patents for C12P 21 - Preparation of peptides or proteins (112,499)
08/2004
08/11/2004EP1444349A2 Process for the preparation of ramipril
08/11/2004EP1444345A1 Conversion of liver stem and progenitor cells to pancreatic functional cells
08/11/2004EP1444333A2 Method for formulating a glucose oxidase enzyme with a desired property or properties and a glucose oxidase enzyme with the desired property
08/11/2004EP1444267A2 Affinity enhancement agents
08/11/2004EP1444262A2 Growth hormone variations in humans and their uses
08/11/2004EP1444254A2 Molecules for disease detection and treatment
08/11/2004EP1444249A1 Method of protein purification
08/11/2004EP1444245A2 Novel chromophores/fluorophores and methods for using the same
08/11/2004EP1443961A2 Glycoprotein compositions
08/11/2004EP1443913A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/11/2004EP1351977B1 Antimicrobial pseudopeptides
08/11/2004EP1242457B1 Intrabodies with defined framework that is stable in a reducing environment and applications thereof
08/11/2004EP0979410B1 Method for determining cytokine receptor activation by the use of an antibody
08/11/2004EP0977859B1 The neurotrophic factor nnt-1
08/11/2004EP0938545B1 Novel methods and compositions for combinatorial-based discovery of new multimeric molecules
08/11/2004EP0927354B1 DIAGNOSTIC METHOD FOR DETECTION OF MOLECULAR FORMS OF EOSINOPHILIC CATIONIC PROTEIN (iso-ECPs)
08/11/2004EP0894135B1 Multivalent and multispecific antigen-binding protein
08/11/2004EP0821728B1 Tie-2 ligands, methods of making and uses thereof
08/11/2004EP0804453A4 Method for detection and treatment of breast cancer
08/11/2004EP0779922B1 Modified human c3 proteins
08/11/2004EP0749472B1 Extracorporeal cell culture and transplantation kits
08/11/2004EP0629132B1 Purified vacuolating toxin from helicobacter pylori and methods to use same
08/11/2004EP0604560B1 Human cyclin e
08/11/2004CN1520424A Immunoglobulins 2
08/11/2004CN1519321A Method for preparing expressed gene for constructing apolipoprotein AIm of human
08/11/2004CN1519256A Polypeptide-gonadotropic releasing homone 9.01 of human and polynucleotide for encoding polypeptide
08/11/2004CN1519255A Polypeptide-DNA mismatching and modifying protein of human 12.98 and polynucleotide for encoding polypeptide
08/11/2004CN1519254A Polypeptide-protein PWWP 9.24 related to malformation syndrome of human and polynucleotide for encoding polypeptide
08/11/2004CN1519253A Polypeptide-EDF-1, endothelial cell differentiation factor 14.75 of human and polynucleotide for encoding polypeptide
08/11/2004CN1519252A Polypeptide-conjugated protein 10.45 of human retina tumour and polynucleotide for encoding polypeptide
08/11/2004CN1519251A Polypeptide-human zinc finger protein 9.45 and polynucleotide for encoding polypeptide
08/11/2004CN1519250A Polypeptide-human ring finger protein 27.17 and polynucleotide for encoding polypeptide
08/11/2004CN1519249A Polypeptide-polypeptide 13.93 for transporting anion in human tissue and polynucleotide for encoding polypeptide
08/11/2004CN1519248A Polypeptide-human Big protein 11.77 and polynucleotide for encoding polypeptide
08/11/2004CN1519247A Polypeptide-human vacuole protein 9, 46 and polynucleotide for encoding the polypeptide
08/11/2004CN1161473C Transgenic avian bioreactor and method for producing recombinant protein or polypeptide by using one
08/11/2004CN1161469C Methods for enhancing the production of viral vaccines in cell culture by interferon suppression
08/11/2004CN1161468C MPL ligand analogs
08/11/2004CN1161458C Novel recombinant baculovirus, construction method thereof and insect pesticidal composition containing same
08/11/2004CN1161455C Strain Producing remarkable amount of epsilon-poly-L-Lysine and process for producing same
08/11/2004CN1161382C Production of recombination human lactoferritin
08/11/2004CN1161380C Method for purifying keratinocyte growth factors
08/11/2004CN1161376C Major outer membrane protein CD of Moraxella
08/11/2004CN1161375C Fusion protein with improved combining activity to target cell receptor
08/11/2004CN1161372C Novel peptide having biological activity
08/11/2004CN1161152C Method and composition useful for inhibition of angiogenesis
08/11/2004CA2457262A1 Process and device for continuous biomolecule production
08/10/2004US6774227 Reating disorders related to cellular overproliferation comprising neutralizing the production or activity of macrophage migration inhibitory factor (mif)
08/10/2004US6774224 ULBP DNA and polypeptides
08/10/2004US6774217 Use of fragile histidine triad gene (fhit) genes and their encoded proteins as diagnostic and therapeutic reagents for the detection and treatment of disease states associated with cell overproliferation
08/10/2004US6774214 Monocyte-derived homolog of FDF03 protein
08/10/2004US6774210 Anti-freeze protein derived from lichen, especially umbilicaria antarctica
08/10/2004US6774116 Prodrugs via acylation with cinnamate
08/10/2004US6774107 Protein for blocking platelet adhesion
08/10/2004US6773915 Detecting antibodies; culture product
08/10/2004US6773908 From open reading frames; vaccines
08/10/2004US6773900 End selection in directed evolution
08/10/2004US6773899 Generating preferential polypeptide; obtain cells, incubate with expression vector containing preferential gene, express vector, recover polypeptide
08/10/2004US6773891 Inducing the production of antibodies, in vivo, that specifically bind to nicotine. these conjugates comprise a nicotine hapten conjugated to an immunogenic carrier protein. the novel conjugates preserve the chirality of nicotine in
08/10/2004US6773701 Expression enhancer for protein synthesis inhibitory genes
08/10/2004CA2273498C Cross-linked protein gels and methods of making them
08/10/2004CA2145388C Method of controlling polypeptide production in bacteria
08/10/2004CA2121041C Composite antibodies of human subgroup iv light chain capable of binding to tag-72
08/09/2004CA2538147A1 Farnesyl dibenzodiazepinone, processes for its production and its use as a pharmaceutical
08/05/2004WO2004065611A1 Method of screening light chain of antibdoy
08/05/2004WO2004065610A1 METHOD FOR PRODUCING α- L-ASPARTYL-L-PHENYLALANINE-β-ESTER AND METHOD FOR PRODUCING α-L-ASPARTYL-L-PHENYLALANINE-α-METHYL ESTER
08/05/2004WO2004065599A1 Lrp4/CORIN DOPAMINE-PRODUCING NEURON PROLIFERATION PRECURSOR CELL MARKER
08/05/2004WO2004065569A2 Multi-functional antibodies
08/05/2004WO2004065540A2 Fusion constructs and use of same to produce antibodies with increased fc receptor binding affinity and effector function
08/05/2004WO2004065419A1 Antibody and use thereof
08/05/2004WO2004065418A1 Anti-pci neutralizing antibody
08/05/2004WO2004065413A1 Novel substances k01-b0171 and process for producing the same
08/05/2004WO2004064750A2 Improved constructs for expressing lysosomal polypeptides
08/05/2004WO2004064724A2 Designed deimmunized monoclonal antibodies for protection against hiv exposure and treatment of hiv infection
08/05/2004WO2004033486A3 Production of homotrimeric fusion proteins
08/05/2004WO2004024077A9 Novel composition and methods for the treatment of psoriasis
08/05/2004WO2003060093A3 METHODS AND COMPOSITIONS FOR PROPAGATING VECTORS CONTAINING TOXIC cDNAs AND ION CHANNEL ASSAY SYSTEMS
08/05/2004WO2003042359A3 Histamine receptor h3 polynucleotides
08/05/2004WO2003039462A3 B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies
08/05/2004WO2003029411A3 Novel cyclooxygenase variants and methods of use
08/05/2004WO2002081731A3 Novel nucleic acids and polypeptides
08/05/2004WO2002074926A3 Myo-inositol oxygenases
08/05/2004US20040154045 Production of human recombinant collagen in the milk of transgenic animals
08/05/2004US20040152879 Comprises receptor protein associated with osteocyte differentiation for identification of modulators associated with treatment bone and tumor disorders
08/05/2004US20040152658 For therapy of animal having a deficiency in a neuron's immediate early gene responsiveness to a stimulus
08/05/2004US20040152638 Protegrins
08/05/2004US20040152170 Clonal myeloma cell lines useful for manufacturing proteins in chemically defined media
08/05/2004US20040152164 62 human secreted proteins
08/05/2004US20040152161 Comprises type I membrane protein receptor for identifying modulators for treatment of cell proliferation, leukopenia, anemia, thrombocytopenia, osteoporosis and neurodegenerative disorders
08/05/2004US20040152157 G-protein coupled receptors
08/05/2004US20040152156 Nucleotide sequences coding counter-ligands for several receptors expressed on lymphocytes for use in diagnosis and treatment of asthma, allergic or inflammatory disease
08/05/2004US20040152155 Method for selectively collecting N-terminal peptide fragment of protein
08/05/2004US20040152143 Growth differentiation factor-9
08/05/2004US20040152139 for diagnosing/treating prostate cancer by administering immunoconjugates; gene expression inhibition; genetic engineering
08/05/2004US20040152078 Genetic engineering
08/05/2004US20040152074 Seroreactive regions on HPV 16 proteins E1 and E2
08/05/2004US20040151720 Cell surface molecule mediating cell adhesion and signal transmission
08/05/2004US20040151719 Human G-protein chemokine receptor (CCR5) HDGNR10
08/05/2004US20040151695 Expression and secretion vector for human interferon alpha and process for producing human interferon alpha by employing same
08/05/2004US20040151669 Lymph cells detected by monoclonal antibodies; diagnosis of autoimmune disease, antiallergens